Linnea A. Polgreen

Linnea A. Polgreen


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
JSJacob Simmering
Jacob Simmering
FTFan Tang
Fan Tang
JCJoseph E. Cavanaugh
Joseph E. Cavanaugh
LPLinnea A. Polgreen
Linnea A. Polgreen
PPPhilip M Polgreen
Philip M Polgreen
Background: Outpatient therapies for urinary tract infections (UTIs) are becoming limited due to antimicrobial resistance. The purpose of this paper is to report how the incidence of hospitalizations for UTIs have varied over time in both men and women and across age groups. We also explore how the severity for UTI hospitalizations has changed and describe the seasonality of UTI hospitalizations. Methods: Using the Nationwide Inpatient Sample, we compute a time-series of UTI incidence and subdivide the series by age and sex. We fit a collection of time-series models to explore how the trend and seasonal intensity varies by age and sex. We modeled changes in severity using regression with available confounders. Results: In 2011, there were approximately 400000 hospitalizations for UTIs with an estimated cost of $2.8 billion. Incidence increased by 52% between 1998 and 2011. The rate of increase was larger among both women and older patients. We found that the seasonal intensity (summer peaks and winter troughs) increased over time among women while decreasing among men. For both men and women, seasonality decreased with advancing age. Relative to controls and adjusted for demographics, we found that costs among UTI patients grew more slowly, patients left the hospital earlier, and patients had lower odds of death. Conclusions: Incidence of UTI hospitalization is increasing and is seasonal, peaking in the summer. However, the severity of UTI admissions seems to be decreasing, indicating that patients previously treated as outpatients may now be admitted to the hospital due to increasing antimicrobial resistance.

16 May 2017 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
CAChris A. Anthony
Chris A. Anthony
RPRyan Peterson
Ryan Peterson
LPLinnea A. Polgreen
Linnea A. Polgreen
DSDaniel Sewell
Daniel Sewell
PPPhilip M Polgreen
Philip M Polgreen
OBJECTIVE: To determine whether the seasonality of surgical site infections (SSIs) can be explained by changes in temperature.DESIGN: Retrospective cohort analysis.SETTING: The National Inpatient Sample database.PATIENTS: All hospital discharges with a primary diagnosis of SSI from 1998 to 2011 were considered cases. Discharges with a primary or secondary diagnoses of specific surgeries commonly associated with SSIs from the previous and current month served as our “at risk” cohort.METHODS: We modeled the national monthly count of SSI cases both nationally and stratified by region, sex, age, and type of institution. We used data from the National Climatic Data Center to estimate the monthly average temperatures for all hospital locations. We modeled the odds of having a primary diagnosis of SSI as a function of demographics, payer, location, patient severity, admission month, year, and the average temperature in the month of admission.RESULTS: SSI incidence is highly seasonal, with the highest SSI incidence in August and the lowest in January. During the study period, there were 26.5% more cases in August than in January (95% CI, 23.3–29.7). Controlling for demographic and hospital-level characteristics, the odds of a primary SSI admission increased by roughly 2.1% per 2.8°C (5°F) increase in the average monthly temperature. Specifically, the highest temperature group, >32.2°C (>90°F), was associated with an increase in the odds of an SSI admission of 28.9% (95% CI, 20.2–38.3) compared to temperatures <4.4°C (<40°F).CONCLUSIONS: At population level, SSI risk is highly seasonal and is associated with warmer weather.Infect Control Hosp Epidemiol2017;38:809–816

3 July 2018 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
AGAllene L. Gremaud
Allene L. Gremaud
LCLucas Carr
Lucas Carr
JSJacob Simmering
Jacob Simmering
NENicholas J. Evans
Nicholas J. Evans
JCJames F. Cremer
James F. Cremer
PPPhilip M. Polgreen
Philip M. Polgreen
Background Sedentary work is hazardous. Over 80% of all US jobs are predominantly sedentary, placing full‐time office workers at increased risk for cardiovascular and metabolic morbidity and mortality. Thus, there is a critical need for effective workplace physical activity interventions. MapTrek is a mobile health platform that gamifies Fitbit use for the purpose of promoting physical activity. The purpose of this study was to test the efficacy of MapTrek for increasing daily steps and moderate‐intensity steps over 10 weeks in a sample of sedentary office workers. Methods and Results Participants included 146 full‐time sedentary office workers aged 21 to 65 who reported sitting at least 75% of their workday. Each participant received a Fitbit Zip to wear daily throughout the intervention. Participants were randomized to either a: (1) Fitbit‐only group or 2) Fitbit + MapTrek group. Physical activity outcomes and intervention compliance were measured with the Fitbit activity monitor. The Fitbit + MapTrek group significantly increased daily steps (+2092 steps per day) and active minutes (+11.2 min/day) compared to the Fitbit‐only arm, but, on average, participants’ steps declined during the study period. Conclusions MapTrek is an effective approach for increasing physical activity at a clinically meaningful level in sedentary office workers, but as with accelerometer use alone, the effect decreases over time. Clinical Trial Registration URL: https://www.clinicaltrials.gov. Unique identifier: NCT03109535.

1 December 2015 in Hypertension
Verified
Journal Article
Closed access
PDF file
LPLinnea A. Polgreen
Linnea A. Polgreen
JHJayoung Han
Jayoung Han
BCBarry L. Carter
Barry L. Carter
GAGail P. Ardery
Gail P. Ardery
CCChristopher S. Coffey
Christopher S. Coffey
PJPaul A. James
Paul A. James
Previous studies have demonstrated the cost-effectiveness of physician–pharmacist collaborations to improve hypertension control. However, most studies have limited generalizability, lacking minority and low-income populations. The Collaboration Among Pharmacist and Physicians to Improve Blood Pressure Now (CAPTION) trial randomized 625 patients from 32 medical offices in 15 states. Each office had an existing clinical pharmacist on staff. Pharmacists in intervention offices communicated with patients and made recommendations to physicians about changes in therapy. Demographic information, blood pressure (BP), medications, and physician visits were recorded. In addition, pharmacists tracked time spent with each patient. Costs were assigned to medications and pharmacist and physician time. Cost-effectiveness ratios were calculated based on changes in BP measurements and hypertension control rates. Thirty-eight percent of patients were black, 14% were Hispanic, and 49% had annual income <$25 000. At 9 months, average systolic BP was 6.1 mm Hg lower (±3.5), diastolic was 2.9 mm Hg lower (±1.9), and the percentage of patients with controlled hypertension was 43% in the intervention group and 34% in the control group. Total costs for the intervention group were $1462.87 (±132.51) and $1259.94 (±183.30) for the control group, a difference of $202.93. The cost to lower BP by 1 mm Hg was $33.27 for systolic BP and $69.98 for diastolic BP. The cost to increase the rate of hypertension control by 1 percentage point in the study population was $22.55. Our results highlight the cost-effectiveness of a clinical pharmacy intervention for hypertension control in primary care settings.

1 November 2017 in Emerging Infectious Diseases
Verified
Journal Article
Open access
JSJacob Simmering
Jacob Simmering
LPLinnea A. Polgreen
Linnea A. Polgreen
DHDouglas B. Hornick
Douglas B. Hornick
DSDaniel Sewell
Daniel Sewell
PPPhilip M Polgreen
Philip M Polgreen
Using the Nationwide Inpatient Sample and US weather data, we estimated the probability of community-acquired pneumonia (CAP) being diagnosed as Legionnaires’ disease (LD). LD risk increases when weather is warm and humid. With warm weather, we found a dose-response relationship between relative humidity and the odds for LD. When the mean temperature was 60°–80°F with high humidity (>80.0%), the odds for CAP being diagnosed with LD was 3.1 times higher than with lower levels of humidity (<50.0%). Thus, in some regions (e.g., the Southwest), LD is rarely the cause of hospitalizations. In other regions and seasons (e.g., the Mid-Atlantic in summer), LD is much more common. Thus, suspicion for LD should increase when weather is warm and humid. However, when weather is cold, dry, or extremely hot, empirically treating all CAP patients for LD might contribute to excessive antimicrobial drug use at a population level.

15 June 2015 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
JSJacob Simmering
Jacob Simmering
LPLinnea A. Polgreen
Linnea A. Polgreen
DCDavid R. Campbell
David R. Campbell
JCJoseph E. Cavanaugh
Joseph E. Cavanaugh
PPPhilip M Polgreen
Philip M Polgreen
OBJECTIVE: To determine the effect of interhospital patient sharing via transfers on the rate of Clostridium difficile infections in a hospital.DESIGN: Retrospective cohort.METHODS: Using data from the Healthcare Cost and Utilization Project California State Inpatient Database, 2005–2011, we identified 2,752,639 transfers. We then constructed a series of networks detailing the connections formed by hospitals. We computed 2 measures of connectivity, indegree and weighted indegree, measuring the number of hospitals from which transfers into a hospital arrive, and the total number of incoming transfers, respectively. Next, we estimated a multivariate model of C. difficile infection cases using the log-transformed network measures as well as covariates for hospital fixed effects, log median length of stay, log fraction of patients aged 65 or older, and quarter and year indicators as predictors.RESULTS: We found an increase of 1 in the log indegree was associated with a 4.8% increase in incidence of C. difficile infection (95% CI, 2.3%–7.4%) and an increase of 1 in log weighted indegree was associated with a 3.3% increase in C. difficile infection incidence (1.5%–5.2%). Moreover, including measures of connectivity in our models greatly improved their fit.CONCLUSIONS: Our results suggest infection control is not under the exclusive control of a given hospital but is also influenced by the connections and number of connections that hospitals have with other hospitals.Infect. Control Hosp. Epidemiol. 2015;36(9):1031–1037